Duopoly model reveals higher R&D risks in cooperative R&D versus noncooperative settings, indicating ownership structure impacts risk behavior.
This paper develops a duopoly model to examine firms' optimal R&D risk choices under cooperative and non‐cooperative R&D with cross‐ownership. We find that firms adopt higher R&D risks in cooperative settings than in non‐cooperative ones. Moreover, equilibrium R&D risks increase with cross‐ownership, and a firm assumes higher risk when it holds a smaller equity stake in its competitor. Our results also reveal that the socially optimal R&D risk exceeds the private optimum. Under cooperative R&D, this risk gap widens as cross‐ownership rises, whereas in non‐cooperative R&D, its trend depends on product substitutability. Extending the model to unilateral ownership, we show that the firm partially owned by its competitor takes on higher R&D risk than the owning firm, though both assume lower risk compared to cross‐ownership. Finally, we demonstrate that R&D risk is higher under Bertrand competition than under Cournot competition. This study contributes to the literature by highlighting the role of ownership structure in shaping firms' risk‐taking behaviors in R&D and offering new insights into the trade‐off between cooperation and competition in innovation.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: